SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.
Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.
SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.
Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.
Temporary Change in PDL Status for Antihypertensives, Sympatholytics Drug Class
Date: September 26, 2022 Attention: All Providers Effective Date: September 26, 2022Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event.
Call to action: The Health and Human Services Commission (HHSC) is aware of a drug shortage for Catapres-TTS patches in the Antihypertensives, Sympatholytics drug class due to the discontinuation of this product by the manufacturer, Boehringer Ingelheim. HHSC received reports of a shortage from MCOs, and the manufacturer verified the shortage.
How this impacts providers: Effective September 26, 2022, HHSC temporarily removed the non-preferred status from the generic product, clonidine transdermal patches, on the preferred drug list (PDL). The preferred status of the brand name products (NDC 00597-0031-34, 00597-0032-34, and 00597-0033-34) will not change to allow for any existing stock available to be utilized.
HHSC removed the non-preferred status for the following generic drugs.
